Tailoring Treatments with AI: Insights from Sanofi’s Shameer Khader

Shameer Khader from Sanofi delves into the transformative role of AI in healthcare, emphasizing a future where tailored treatments and human-AI hybrid interactions coexist harmoniously.
In a recent interview at Machinecon USA 2023, Shameer Khader, a leader from the biopharmaceutical company Sanofi, delved into the transformative role of artificial intelligence (AI) in the realm of healthcare and pharmaceuticals. His insights provide a glimpse into the future of patient-centric treatments and the harmonious integration of AI in healthcare. Chasing the Miracles of Science with AI Sanofi, as Khader describes, is a company dedicated to "chasing the miracles of science." They harness the power of data, AI, machine intelligence, and the invaluable data from clinical trials and experiments. Khader leads the computational biology cluster within Sanofi, a part of the precision medicine function. The primary goal of precision medicine is to develop treatments tailored to indi
Subscribe or log in to Continue Reading

Uncompromising innovation. Timeless influence. Your support powers the future of independent tech journalism.

Already have an account? Sign In.

📣 Want to advertise in AIM Media House? Book here >

Picture of 理想
理想
AIM is the world's leading media and analyst firm dedicated to advancements and innovations in Artificial Intelligence. Reach out to us at info@aimmediahouse.com
25 July 2025 | 583 Park Avenue, New York
The Biggest Exclusive Gathering of CDOs & AI Leaders In United States

Subscribe to our Newsletter: AIM Research’s most stimulating intellectual contributions on matters molding the future of AI and Data.